Stefania Crucitta
0000-0002-5046-9048
University of Pisa
8 papers found
Refreshing results…
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7
Missing publications? Search for publications with a matching author name.